Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Drilon

Showing results (21-30 of 268) with videos related to

Pageof 27
Sort By:
Cancer Discovery|December 2, 2024
Precision Oncology: 2024 in ReviewMatteo Repetto, Nicole Fernandez, Alexander Drilon, et al.
Cancer Genetics|June 21, 2022
EditorialMarilyn M Li, Alexander Drilon, Theodore W Laetsch
Clinical Lung Cancer|November 11, 2010
Extended-duration therapy in advanced non-small-cell lung cancer: promise and pitfallsBenjamin Levy, Alexander Drilon, Karleung Siu, et al.
Cancer Discovery|December 2, 2025
Precision Oncology: 2025 in ReviewNicholas Mai, Nicole Fernandez, Alexander Drilon, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2021
NTRK fusions in lung cancer: From biology to therapyGuilherme Harada, Fernando C Santini, Clare Wilhelm, et al.
JTO Clinical and Research Reports|January 1, 2024
Spontaneous Bilateral Chylothorax Development During Alectinib Therapy for <i>ALK</i>-Rearranged NSCLC-A Case ReportSunanjay Bajaj, Andrew Chow, Alexander Drilon, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2019
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)Ana C Z Gelatti, Alexander Drilon, Fernando C Santini
Drugs|July 12, 2024
RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and FutureMonica F Chen, Matteo Repetto, Clare Wilhelm, et al.
Cancer|April 2, 2025
Targeting ROS1 rearrangements in non-small cell lung cancer: Current insights and future directionsAntoine Desilets, Matteo Repetto, Soo-Ryum Yang, et al.
Nature Reviews. Clinical Oncology|February 22, 2023
Rare molecular subtypes of lung cancerGuilherme Harada, Soo-Ryum Yang, Emiliano Cocco, et al.
Pageof 27

Showing results (21-30 of 268) with videos related to

Sort By:
Pageof 27
Cancer Discovery|December 2, 2024
Precision Oncology: 2024 in ReviewMatteo Repetto, Nicole Fernandez, Alexander Drilon, et al.
Cancer Genetics|June 21, 2022
EditorialMarilyn M Li, Alexander Drilon, Theodore W Laetsch
Clinical Lung Cancer|November 11, 2010
Extended-duration therapy in advanced non-small-cell lung cancer: promise and pitfallsBenjamin Levy, Alexander Drilon, Karleung Siu, et al.
Cancer Discovery|December 2, 2025
Precision Oncology: 2025 in ReviewNicholas Mai, Nicole Fernandez, Alexander Drilon, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2021
NTRK fusions in lung cancer: From biology to therapyGuilherme Harada, Fernando C Santini, Clare Wilhelm, et al.
JTO Clinical and Research Reports|January 1, 2024
Spontaneous Bilateral Chylothorax Development During Alectinib Therapy for <i>ALK</i>-Rearranged NSCLC-A Case ReportSunanjay Bajaj, Andrew Chow, Alexander Drilon, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2019
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)Ana C Z Gelatti, Alexander Drilon, Fernando C Santini
Drugs|July 12, 2024
RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and FutureMonica F Chen, Matteo Repetto, Clare Wilhelm, et al.
Cancer|April 2, 2025
Targeting ROS1 rearrangements in non-small cell lung cancer: Current insights and future directionsAntoine Desilets, Matteo Repetto, Soo-Ryum Yang, et al.
Nature Reviews. Clinical Oncology|February 22, 2023
Rare molecular subtypes of lung cancerGuilherme Harada, Soo-Ryum Yang, Emiliano Cocco, et al.
Pageof 27